Studies show that though it is of common sense that treatment should be continued over a period of time, it unfortunately is not common practice especially among patients suffering from osteoporosis . The recent studies conducted by the International Osteoporosis Foundation (IOF) found that lack of regime to a prescribed therapy is a ‘worldwide problem of striking magnitude’. They warn that if this adherence gap continues, in 2050, the worldwide cost of burden of treatment would increase to a minimum of US1.5 billion.
But cost aside it would be the unfortunate truth that would also mean there will be more people who will lose their mobility, independence and productivity as a result of osteoporosis. As a result, more families will have the responsibilities to give care for family members, which could mean further loss of productivity.
Explaining that osteoporosis, a disease of the bone, that usually affects 1 in every 3 women and 1 in every 5 man. This disease reduces the density and quality of the bone that leads to weakness of the skeleton and increased risk of fracture. The most common sites for osteoporotic fracture are the spine, hip and wrist.
Prof. Jean-Yves Reginster, of the University of Liege, Belgium, said that it is treatable condition, yet lack of faithfulness to treatment is a huge problem, with many patients finding it difficult to continue with medication for the recommended long-term period. Professor Reginster is the head of the university’s Center for Investigation in Bone and Articular Cartilage Metabolism.